Brian J. Angus

Oxford, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 78 publications

Phase II multicentre double-blind randomised controlled trial of a Bivalent VaccInation against Salmonella Typhi and Paratyphi A (BiVISTA) using a controlled human infection model of paratyphoid A infection: study protocol.

Phase II multicentre double-blind randomised controlled trial of a Bivalent VaccInation against Salmonella Typhi and Paratyphi A (BiVISTA) using a controlled human infection model of paratyphoid A infection: study protocol.

Journal: BMJ open

Published: January 27, 2026

Safety, Efficacy, and Immunogenicity of a Salmonella Paratyphi A Vaccine.

Safety, Efficacy, and Immunogenicity of a Salmonella Paratyphi A Vaccine.

Journal: The New England journal of medicine

Published: October 29, 2025

It never rains but pours: disseminated nocardiosis in a renal transplant patient from Nigeria - a case report.

It never rains but pours: disseminated nocardiosis in a renal transplant patient from Nigeria - a case report.

Journal: BMC infectious diseases

Published: September 22, 2025

T cell memory response to MPXV infection exhibits greater effector function and migratory potential compared to MVA-BN vaccination.

T cell memory response to MPXV infection exhibits greater effector function and migratory potential compared to MVA-BN vaccination.

Journal: Nature communications

Published: June 19, 2024

MAVMET trial: maraviroc and/or metformin for metabolic dysfunction associated fatty liver disease in adults with suppressed HIV.

MAVMET trial: maraviroc and/or metformin for metabolic dysfunction associated fatty liver disease in adults with suppressed HIV.

Journal: AIDS (London, England)

Published: May 31, 2024

R21 in Matrix-M adjuvant in UK malaria-naive adult men and non-pregnant women aged 18-45 years: an open-label, partially blinded, phase 1-2a controlled human malaria infection study.

R21 in Matrix-M adjuvant in UK malaria-naive adult men and non-pregnant women aged 18-45 years: an open-label, partially blinded, phase 1-2a controlled human malaria infection study.

Journal: The Lancet. Microbe

Published: October 05, 2023

Evaluation of a novel malaria anti-sporozoite vaccine candidate, R21 in Matrix-M adjuvant, in the UK and Burkina Faso: two phase 1, first-in-human trials.

Evaluation of a novel malaria anti-sporozoite vaccine candidate, R21 in Matrix-M adjuvant, in the UK and Burkina Faso: two phase 1, first-in-human trials.

Journal: The Lancet. Microbe

Published: October 05, 2023

Accelerating clinical development of a live attenuated vaccine against Salmonella Paratyphi A (VASP): study protocol for an observer-participant-blind randomised control trial of a novel oral vaccine using a human challenge model of Salmonella Paratyphi A infection in healthy adult volunteers.

Accelerating clinical development of a live attenuated vaccine against Salmonella Paratyphi A (VASP): study protocol for an observer-participant-blind randomised control trial of a novel oral vaccine using a human challenge model of Salmonella Paratyphi A infection in healthy adult volunteers.

Journal: BMJ open

Published: May 24, 2023

Understanding the treatment benefit of hyperimmune anti-influenza intravenous immunoglobulin (Flu-IVIG) for severe human influenza.

Understanding the treatment benefit of hyperimmune anti-influenza intravenous immunoglobulin (Flu-IVIG) for severe human influenza.

Journal: JCI insight

Published: November 28, 2022

Anomalies in the review process and interpretation of the evidence in the NICE guideline for chronic fatigue syndrome and myalgic encephalomyelitis.

Anomalies in the review process and interpretation of the evidence in the NICE guideline for chronic fatigue syndrome and myalgic encephalomyelitis.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: September 25, 2022

Malaria patient spectrum representation in therapeutic clinical trials of uncomplicated malaria: a scoping review of the literature.

Malaria patient spectrum representation in therapeutic clinical trials of uncomplicated malaria: a scoping review of the literature.

Journal: Malaria journal

Published: June 28, 2022

Mucosal-Associated Invariant T cells exhibit distinct functional signatures associated with protection against typhoid fever.

Mucosal-Associated Invariant T cells exhibit distinct functional signatures associated with protection against typhoid fever.

Journal: Cellular immunology

Published: April 07, 2022

Showing 1-12 of 78

Last Updated: 09/26/2026